KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Asset Writedowns and Impairment (2022 - 2025)

Historic Asset Writedowns and Impairment for Charles River Laboratories International (CRL) over the last 4 years, with Q3 2025 value amounting to $5.0 million.

  • Charles River Laboratories International's Asset Writedowns and Impairment rose 6128.2% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.2 million, marking a year-over-year increase of 9119.16%. This contributed to the annual value of $51.8 million for FY2024, which is 2365.49% up from last year.
  • Per Charles River Laboratories International's latest filing, its Asset Writedowns and Impairment stood at $5.0 million for Q3 2025, which was up 6128.2% from $20.6 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Asset Writedowns and Impairment high stood at $27.0 million for Q4 2024, and its period low was -$7000.0 during Q3 2023.
  • In the last 4 years, Charles River Laboratories International's Asset Writedowns and Impairment had a median value of $9.6 million in 2023 and averaged $10.8 million.
  • The largest annual percentage gain for Charles River Laboratories International's Asset Writedowns and Impairment in the last 5 years was 12607142.86% (2024), contrasted with its biggest fall of 8038.61% (2024).
  • Quarter analysis of 4 years shows Charles River Laboratories International's Asset Writedowns and Impairment stood at $6.7 million in 2022, then soared by 134.25% to $15.7 million in 2023, then skyrocketed by 71.88% to $27.0 million in 2024, then plummeted by 81.55% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q3 2025, $20.6 million for Q2 2025, and $10.6 million during Q1 2025.